Participants’ demographic characteristics
| Characteristic | No. (%) of participants n = 30 |
|---|---|
| Role | |
| Decision-maker | 14 (46.7) |
| Academic | 5 (16.7) |
| Industry representative | 4 (13.3) |
| Patient advisor | 4 (13.3) |
| International expert | 3 (10.0) |
| Institution type | |
| Academic | 6 (20.0) |
| Industry | 4 (13.3) |
| Government (e.g., ministry) | 4 (13.3) |
| Health technology assessment or health economics not-for-profit organization | 4 (13.3) |
| Federal or provincial health authority | 6 (20.0) |
| Federal or provincial pharmaceutical pricing negotiation | 2 (6.7) |
| Patient advisory board | 4 (13.3) |
| Sex | |
| Male | 14 (46.7) |
| Female | 16 (53.3) |
| Region | |
| Central Canada | 15 (50.0) |
| Atlantic Canada | 2 (6.7) |
| Prairie provinces (Manitoba, Saskatchewan, Alberta) | 6 (20.0) |
| British Columbia | 4 (13.3) |
| Outside Canada (Scotland, England, United States) | 3 (10.0) |